Sensei Biotherapeutics, Inc.
SNSE
$21.08
$0.080.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.29% | 37.02% | 30.89% | 14.11% | -4.80% |
| Total Depreciation and Amortization | -89.73% | -89.76% | -88.72% | -89.73% | 0.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -61.85% | -43.51% | -48.99% | -59.58% | 5.67% |
| Change in Net Operating Assets | 14.40% | -22.22% | -1,850.59% | 39.80% | 162.50% |
| Cash from Operations | 33.29% | 34.44% | -2.02% | 6.85% | 6.02% |
| Capital Expenditure | -- | -- | 85.32% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 166.04% | -86.50% | 22.05% | 23.14% | -138.14% |
| Cash from Investing | 166.04% | -86.50% | 26.78% | 24.63% | -138.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 45.41% | 25.49% | -56.22% | -6.03% | -5.61% |
| Issuance of Common Stock | -84.62% | -- | -76.19% | -- | -23.53% |
| Repurchase of Common Stock | -- | -- | -- | 70.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42.78% | 25.49% | 6.67% | -2.39% | 54.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.27% | -127.56% | 186.63% | 94.31% | -647.78% |